![Bernhard Kirschbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernhard Kirschbaum
Directeur/Membre du Conseil chez
REDX PHARMA LTD
Profil
Bernhard Kirschbaum's current job(s) include being the Chairman at OMEICOS Therapeutics GmbH, an Independent Non-Executive Director at Redx Pharma Plc, a Director at BioMedx Group, Inc., a Scientific Advisor at FutuRx Ltd., a Member-Supervisory Board at BioMed X GmbH, and a Member-Supervisory Board at Amarna Therapeutics BV since 2019.
Dr. Kirschbaum's former job(s) include being the Chairman-Supervisory Board at Protagen AG, a Research Director at Merck Serono SA from 2005 to 2012, a Director at Enlivex Therapeutics Ltd., a Director at KAHR Medical Ltd., an Independent Director at Enlivex Therapeutics Ltd., a Principal at Institut Pasteur, a Principal at The Rockefeller University, and a Vice President-Discovery Research at Sanofi-Aventis Deutschland GmbH.
Dr. Kirschbaum obtained a doctorate degree from Universität Konstanz in 1989.
Postes actifs de Bernhard Kirschbaum
| Sociétés | Poste | Début |
|---|---|---|
| REDX PHARMA LTD | Directeur/Membre du Conseil | 01/01/2016 |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Président | - |
BioMedx Group, Inc.
 BioMedx Group, Inc. Medical SpecialtiesHealth Technology Develops photo-realistic 3-D and holographic digital human modeling devices for medical and healthcare industry | Directeur/Membre du Conseil | - |
Amarna Therapeutics BV
 Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Develops gene and immune-therapies | Directeur/Membre du Conseil | 16/10/2019 |
BioMed X GmbH
 BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in oncology, neuroscience, respiratory medicine, microbiology and diagnostics | Directeur/Membre du Conseil | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Consultant / Advisor | - |
Anciens postes connus de Bernhard Kirschbaum
| Sociétés | Poste | Fin |
|---|---|---|
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Directeur/Membre du Conseil | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Directeur/Membre du Conseil | - |
| ENLIVEX LTD. | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Bernhard Kirschbaum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Protagen AG
 Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Health Technology |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Redx Pharma Plc
 Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
BioMedx Group, Inc.
BioMedx Group, Inc. Medical SpecialtiesHealth Technology Develops photo-realistic 3-D and holographic digital human modeling devices for medical and healthcare industry | Health Technology |
BioMed X GmbH
BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in oncology, neuroscience, respiratory medicine, microbiology and diagnostics | Commercial Services |
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Develops gene and immune-therapies | Health Services |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
